Is Henoch-Schönlein purpura (HSP) associated with nephritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is HSP Associated with Nephritis?

Yes, Henoch-Schönlein purpura (HSP) is definitively associated with nephritis, occurring in approximately 20-50% of children and representing a major determinant of long-term morbidity and mortality. 1, 2

Epidemiology and Clinical Significance

  • Renal involvement occurs in 40% of pediatric HSP cases, manifesting as hematuria and/or proteinuria, and represents the primary source of long-term morbidity rather than a separate complication. 3, 1

  • Adults with HSP have more severe renal involvement at presentation compared to children, with 32% showing renal insufficiency (creatinine clearance <50 ml/min) at diagnosis, typically associated with proteinuria (99%) and/or hematuria (93%). 4

  • The long-term prognosis of HSP is directly dependent on the severity of renal involvement, with HSP nephritis leading to chronic kidney disease in up to 20% of pediatric patients after 20 years of follow-up. 3, 5

Diagnostic Criteria for HSP with Nephritis

  • HSP nephritis is diagnosed when palpable purpura is present plus renal involvement (hematuria and/or proteinuria), with or without arthralgia/arthritis or abdominal pain. 1, 2

  • The classic triad of hematuria, purpuric lesions, and ankle pain is specifically diagnostic of HSP with renal involvement. 2

  • Urinalysis with microscopy is essential at every clinical visit to detect red blood cell casts and dysmorphic RBCs, which indicate glomerular involvement and help assess severity of glomerulonephritis. 2

Pathophysiology

  • HSP nephritis is characterized by IgA deposition in the glomerular mesangium, similar to IgA nephropathy, with increased serum IgA concentrations and IgA-containing circulating immune complexes in vessel walls. 3, 5

  • The disease involves abnormalities of IgA1 exclusively (not IgA2), possibly due to abnormal glycosylation of O-linked oligosaccharides unique to the hinge region of IgA1 molecules. 3

  • Endocapillary glomerulonephritis is the most frequent histologic lesion on renal biopsy (61% of cases), with crescentic glomerulonephritis representing the most severe form. 4

Prognosis and Outcomes

  • In adults, HSP nephritis has a poor prognosis: only 20% achieve clinical remission (absence of proteinuria, hematuria, and normal renal function), while 11% reach end-stage renal failure, 13% exhibit severe renal failure (CrCl <30 ml/min), and 14% develop moderate renal insufficiency (CrCl <50 ml/min). 4

  • Patient survival in adult HSP is only 74% at long-term follow-up, with the first cause of death being carcinoma (most commonly respiratory or digestive tract). 4

  • Prognostic factors for poor renal outcomes include: renal function impairment and proteinuria level at presentation, degree of interstitial fibrosis on biopsy, percentage of sclerotic glomeruli, and presence of glomeruli with fibrinoid necrosis. 4

Common Pitfalls

  • Failing to perform urinalysis at every clinical visit can lead to delayed detection of renal relapse or progression, as HSP nephritis can develop insidiously even after initial presentation. 1

  • Assuming HSP is always self-limited is dangerous—while one-third of patients have recurrences, the renal involvement can progress to end-stage renal disease, particularly in adults. 3, 4

  • Not recognizing that adults have worse outcomes than children may lead to inadequate monitoring; adults are more likely to have severe initial renal involvement with higher risk of progression. 6, 4

References

Guideline

Henoch-Schönlein Purpura Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

HSP Nephritis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Henoch-Schönlein Purpura in adults: outcome and prognostic factors.

Journal of the American Society of Nephrology : JASN, 2002

Research

Henoch-Schönlein purpura nephritis: an update.

European journal of pediatrics, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the management and treatment approach for a patient with Henoch-Schönlein purpura (HSP)?
What blood workup is recommended for a patient suspected of having Henoch-Schönlein Purpura (HSP)?
What test is most likely to be abnormal in a well-appearing boy with a rash, joint pain, and palpable purpura in his lower extremities?
What is the most likely cause of a patient's current presentation with abdominal pain, bilateral ankle swelling, hematuria, and proteinuria, who has a history of Henoch-Schonlein Purpura (HSP) and a family history of Systemic Lupus Erythematosus (SLE)?
What warning signs in a patient diagnosed with Henoch-Schönlein Purpura (HSP) require immediate medical attention?
Is ibuprofen effective for treating occasional headaches in adults or adolescents?
What is the optimal blood pressure target for a Chinese patient with a history of stroke, currently taking aspirin (acetylsalicylic acid) 81-325mg daily, considering permissive hypertension versus the CAST (Chinese Acute Stroke Trial) study target?
What are the potential causes and treatments of night sweats in a patient?
What is the recommended initial anticoagulation therapy and subsequent management approach for a patient with Deep Vein Thrombosis (DVT)?
How long after smoking Tetrahydrocannabinol (THC) is an individual considered under the influence and what laboratory test confirms this?
What is the differential diagnosis (dd) and recommended treatment for a 3-month-old boy presenting with dry cough, vomiting, nocturnal fever, and excessive crying?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.